Ambrisentan (generic)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ambrisentan (generic), covering 2019-04-26 to 2019-04-26. Get the full timeline:
Most recent: FDA Approved: AMBRISENTAN — Original Application (Cipla USA Inc.)